Medical Research
Holstebro, 7500, Denmark
NCT Number: NCT00857909
This study will investigate whether retaining potassium in the body will lead to changes in blood pressure and changes in blood and urine samples.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 1
Holstebro, 7500, Denmark
The purpose is to measure the effect of amiloride and spironolactone on:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 tablet twice a day
1 tablet twice a day
Placebo
5mg twice daily
Time frame: 2 years
Regional Hospital Holstebro
Other
The Effect of Amiloride and Spironolactone Measured on Cardiovascular and Kidney Related Variables in Healthy Subjects in a Double-blinded, Randomised, Placebo-controlled, Cross-over Study
Acronym: SPAS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07648758
Cardiovascular Diseases, High Blood Pressure
Dallas, Texas, United States
View Trial DetailsNCT06508619
Cardiovascular Diseases, High Blood Pressure
Delft, South Holland, Netherlands
View Trial DetailsNCT04255745
Atrophy, Behavior
Chicago, Illinois, United States
View Trial DetailsNCT04114669
Cardiovascular Diseases, High Blood Pressure
New York, United States
View Trial Details